Similar articles

• High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.

  Vaillancourt DE, Spraker MB, Prodoehl J, Abraham I, Corcos DM, Zhou XJ, Comella CL, Little DM. Vaillancourt DE, et al. Neurology. 2009 Apr 21;72(16):1378-84. doi: 10.1212/01.wnl.0000340982.01727.6e. Epub 2009 Jan 7. Neurology. 2009. PMID: 19129507 Free PMC article.
• Functional neuroanatomy of the basal ganglia in Parkinson's disease.

  Wichmann T, DeLong MR. Wichmann T, et al. Adv Neurol. 2003;91:9-18. Adv Neurol. 2003. PMID: 12442660 Review. No abstract available.
• Individual dopaminergic neurons show raised iron levels in Parkinson disease.

  Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM. Oakley AE, et al. Neurology. 2007 May 22;68(21):1820-5. doi: 10.1212/01.wnl.0000262033.01945.9a. Neurology. 2007. PMID: 17515544
• Serum uric acid and clinical progression in Parkinson disease: potential biomarker for nigrostriatal failure.

  Schiess M, Oh I. Schiess M, et al. Arch Neurol. 2008 Jun;65(6):698-9. doi: 10.1001/archneur.65.6.698. Arch Neurol. 2008. PMID: 18541788 No abstract available.
• Parkinson's disease is a neuropsychiatric disorder.

  Agid Y, Arnulf I, Bejjani P, Bloch F, Bonnet AM, Damier P, Dubois B, François C, Houeto JL, Iacono D, Karachi C, Mesnage V, Messouak O, Vidailhet M, Welter ML, Yelnik J. Agid Y, et al. Adv Neurol. 2003;91:365-70. Adv Neurol. 2003. PMID: 12442695 Review. No abstract available.